CONTEXT THERAPEUTICS INC. Operating Cash Flow
CONTEXT THERAPEUTICS INC. (CNTX) reported Operating Cash Flow of -$18.45 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-05
- CONTEXT THERAPEUTICS INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$7.02M.
- CONTEXT THERAPEUTICS INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$11.43M.
- CONTEXT THERAPEUTICS INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$8.94M.
- CONTEXT THERAPEUTICS INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$6.58M.
- CONTEXT THERAPEUTICS INC. net cash provided by (used in) operating activities for fiscal 2025 was -$26.39M.
- CONTEXT THERAPEUTICS INC. net cash provided by (used in) operating activities for fiscal 2024 was -$14.56M.
- CONTEXT THERAPEUTICS INC. net cash provided by (used in) operating activities for fiscal 2023 was -$21.05M.
- CONTEXT THERAPEUTICS INC. net cash provided by (used in) operating activities for fiscal 2022 was -$13.55M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$7.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$18.45M 10-Q · filed 2026-08-05 | -$27.39M derived: sum of 3 quarters · filed 2026-08-05 | -$33.97M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$11.43M 10-Q · filed 2026-05-06 | -$20.37M derived: sum of 2 quarters · filed 2026-05-06 | -$26.95M derived: sum of 3 quarters · filed 2026-05-06 | -$32.79M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$8.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$15.52M derived: sum of 2 quarters · filed 2026-03-23 | -$21.36M derived: sum of 3 quarters · filed 2026-08-05 | -$26.39M 10-K · filed 2026-03-23 |
| 2025-09-30 | -$6.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$12.41M derived: sum of 2 quarters · filed 2026-08-05 | -$17.44M 10-Q · filed 2025-11-05 | -$22.35M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$5.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$10.86M 10-Q · filed 2026-08-05 | -$15.77M derived: sum of 3 quarters · filed 2026-08-05 | -$17.70M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$5.03M 10-Q · filed 2026-05-06 | -$9.94M derived: sum of 2 quarters · filed 2026-05-06 | -$11.87M derived: sum of 3 quarters · filed 2026-05-06 | -$15.22M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$4.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$6.84M derived: sum of 2 quarters · filed 2026-03-23 | -$10.20M derived: sum of 3 quarters · filed 2026-03-23 | -$14.56M 10-K · filed 2026-03-23 |
| 2024-09-30 | -$1.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$5.29M derived: sum of 2 quarters · filed 2025-11-05 | -$9.65M 10-Q · filed 2025-11-05 | -$16.88M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | -$3.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$7.72M 10-Q · filed 2025-08-06 | -$14.94M derived: sum of 3 quarters · filed 2025-08-06 | -$18.40M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | -$4.36M 10-Q · filed 2025-05-07 | -$11.59M derived: sum of 2 quarters · filed 2025-05-07 | -$15.05M derived: sum of 3 quarters · filed 2025-05-07 | -$19.68M derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | -$7.23M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$10.69M derived: sum of 2 quarters · filed 2025-03-20 | -$15.32M derived: sum of 3 quarters · filed 2025-03-20 | -$21.05M 10-K · filed 2025-03-20 |
| 2023-09-30 | -$3.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$8.09M derived: sum of 2 quarters · filed 2024-11-06 | -$13.82M 10-Q · filed 2024-11-06 | -$17.75M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | -$4.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$10.36M 10-Q · filed 2024-08-07 | -$14.29M derived: sum of 3 quarters · filed 2024-08-07 | -$17.28M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | -$5.73M 10-Q · filed 2024-05-08 | -$9.66M derived: sum of 2 quarters · filed 2024-05-08 | -$12.65M derived: sum of 3 quarters · filed 2024-05-08 | -$15.46M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$3.93M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$6.92M derived: sum of 2 quarters · filed 2024-03-21 | -$9.73M derived: sum of 3 quarters · filed 2024-03-21 | -$13.55M 10-K · filed 2024-03-21 |
| 2022-09-30 | -$2.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$5.80M derived: sum of 2 quarters · filed 2023-11-09 | -$9.62M 10-Q · filed 2023-11-09 | -$14.58M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$2.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$6.63M 10-Q · filed 2023-08-09 | -$11.59M derived: sum of 3 quarters · filed 2023-08-09 | -$11.63M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | -$3.82M 10-Q · filed 2023-05-10 | -$8.78M derived: sum of 2 quarters · filed 2023-05-10 | -$8.83M derived: sum of 3 quarters · filed 2023-05-10 | -$10.90M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$4.96M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$5.01M derived: sum of 2 quarters · filed 2023-03-22 | -$7.08M derived: sum of 3 quarters · filed 2023-03-22 | -$8.80M 10-K · filed 2023-03-22 |
| 2021-09-30 | -$43.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$2.12M derived: sum of 2 quarters · filed 2022-11-09 | -$3.84M 10-Q · filed 2022-11-09 | -$4.01M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$2.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$3.79M 10-Q · filed 2022-08-11 | -$3.97M derived: sum of 3 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$1.72M 10-Q · filed 2022-05-11 | -$1.89M derived: sum of 2 quarters · filed 2022-05-11 | ||
| 2020-12-31 | -$176.03K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | -$1.03M 10-K · filed 2022-03-23 | ||
| 2020-09-30 | -$858.60K 10-Q · filed 2021-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |